CDK5 anticorps (pTyr15)
-
- Antigène Voir toutes CDK5 Anticorps
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
-
Épitope
- pTyr15
-
Reactivité
- Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDK5 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Réactivité croisée
- Souris, Rat
- Homologie
- Cow,Horse,Chicken,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic phosphopeptide derived from human CDK5 around the phosphorylation site of Tyr15
- Isotype
- IgG
- Top Product
- Discover our top product CDK5 Anticorps primaire
-
-
- Indications d'application
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Date de péremption
- 12 months
-
-
Roscovitine treatment caused impairment of fertilizing ability in mice." dans: Toxicology letters, Vol. 237, Issue 3, pp. 200-9, (2015) (PubMed).
: "
-
Roscovitine treatment caused impairment of fertilizing ability in mice." dans: Toxicology letters, Vol. 237, Issue 3, pp. 200-9, (2015) (PubMed).
-
- Antigène
- CDK5 (Cyclin-Dependent Kinase 5 (CDK5))
- Autre désignation
- CDK5 (CDK5 Produits)
- Synonymes
- anticorps PSSALRE, anticorps AW048668, anticorps Crk6, anticorps CDK5, anticorps CG8203, anticorps DmCdk5, anticorps Dmel\\CG8203, anticorps cdk5, anticorps zgc:101604, anticorps cyclin dependent kinase 5, anticorps cyclin-dependent kinase 5, anticorps Cyclin-dependent kinase 5, anticorps cyclin-dependent kinase 5 L homeolog, anticorps Cyclin-dependent-like kinase 5, anticorps CDK5, anticorps Cdk5, anticorps cdk5, anticorps cdk5.L, anticorps cdk-5
- Sujet
-
Synonyms: Cdk5 phospho Y15, p-Cdk5Y15, Cdk 5, Cell division protein kinase 5, Crk6, Cyclin dependent kinase 5, Protein kinase CDK5 splicing, PSSALRE, Serine threonine protein kinase PSSALRE, Tau protein kinase II catalytic subunit, TPKII catalytic subunit, CDK5_HUMAN.
Background: CDK5 (Cyclin Dependent Kinase 5) is serine/threonine kinase involved in synaptic regulation and neuronal development, phosphorylates synaptic protein Pctaire1, regulates acetylcholine receptor expression. CDK5 is a member of the cyclindependent kinase family of serine/threonine kinases. It is present in numerous mammalian tissues including kidney, testes, and ovary. Its activity is detected almost exclusively in brain extracts. Neuronal and muscle cells contain the highest amount of this protein. Similar to other Cdks, monomeric Cdk5 displays no enzymatic activity, but Cdk5 is not activated by cyclins. Instead, the p35 protein, which is expressed solely in the brain, activates Cdk5. Cdk5 interacts with D1 and D3 type G1 cyclins and can phosphorylate histone H1, TAU, MAP2 and NF-H and NF-M. Cdk5 activity is involved in terminal differentiation of neurons and muscle cells.
- ID gène
- 1020
- Pathways
- Cycle Cellulaire, Regulation of Muscle Cell Differentiation, Synaptic Membrane, Regulation of Cell Size, Skeletal Muscle Fiber Development, Synaptic Vesicle Exocytosis
-